Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer

BACKGROUND: The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy variants and to correlate mutational load to clinical data. METHODS: Circulating cell-free DNA was ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Qvick, Alvida, Stenmark, Bianca, Carlsson, Jessica, Isaksson, Johan, Karlsson, Christina, Helenius, Gisela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254966/
https://www.ncbi.nlm.nih.gov/pubmed/34217228
http://dx.doi.org/10.1186/s10020-021-00331-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254966/
https://www.ncbi.nlm.nih.gov/pubmed/34217228
http://dx.doi.org/10.1186/s10020-021-00331-1

Ejemplares similares